Parecoxib Sodium
-
Catalog numberB1989-50
-
PricePlease ask
-
Size50 mg
-
-
Alternative_nameSodium ((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)(propionyl)amide; SC-69124A; Dynastat
-
DescriptionParecoxib sodium is an injectable prodrug of valdecoxib, that acts as a potent and selective inhibitor of cyclooxygenase-2 (COX-2). Useful for the short-term treatment of postoperative pain in adults.
-
CAS Number198470-85-8
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₉H₁₇N₂NaO₄S
-
Molecular Weight392.4
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA non-steroidal anti-inflammatory drug (NSAID) and a potent cyclooxygenase-2 (COX-2) inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID15895902
-
SMILESCCC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C.[Na+]
-
InChiInChI=1S/C19H18N2O4S.Na/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15;/h4-12H,3H2,1-2H3,(H,21,22);/q;+1/p-1
-
InChi KeyHQPVVKXJNZEAFW-UHFFFAOYSA-M
-
MSDS AvailableYes
-
Gene target
-
Short nameParecoxib Sodium
-
Alternative nameParecoxib Sodium
-